Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule

Clinical and Vaccine Immunology

Volumn 20, Issue 7, 2013, Pages 1041-1047

  Scott, Andrew E ^a   Laws, Thomas R ^a   D'Elia, Riccardo V ^a   Stokes, Margaret G M ^a   Nandi, Tannistha ^b   Williamson, E Diane ^a   Tan, Patrick ^b   Prior, Joann L ^a   Atkins, Timothy P ^a,c  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPTOSE; IMMUNOGLOBULIN G; LIVE VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERIAL STRAIN; BURKHOLDERIA THAILANDENSIS; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; INFECTION CONTROL; INFECTION PREVENTION; MELIOIDOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL VACCINES; BURKHOLDERIA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MELIOIDOSIS; MICE; MICE, INBRED BALB C; SURVIVAL ANALYSIS; VACCINES, ATTENUATED;

EID: 84880473026     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00113-13     Document Type: Article

References (44)

1. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416. (Pubitemid 40548298)
2. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. 2002. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8:225-230. (Pubitemid 34202453)
3. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.
4. Chaowagul W, Suputtamongkol Y, Dance DAB, Rajchanuvong A, Pattara J, White NJ. 1993. Relapse in melioidosis: incidence and risk factors. J. Infect. Dis. 168:1181-1185. (Pubitemid 23317133)
5. Patel N, Conejero L, De RM, Easton A, Bancroft GJ, Titball RW. 2011. Development of vaccines against Burkholderia pseudomallei. Front. Microbiol. 2:198.
6. Haque A, Chu K, Easton A, Stevens MP, Galyov EE, Atkins T, Titball R, Bancroft GJ. 2006. A live experimental vaccine against Burkholderia pseudomallei elicits CD4 T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J. Infect. Dis. 194:1241-1248. (Pubitemid 44630969)
7. Stevens MP, Haque A, Atkins T, Hill J, Wood MW, Easton A, Nelson M, Underwood-Fowler C, Titball RW, Bancroft GJ, Galyov EE. 2004. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 150:2669-2676. (Pubitemid 39173270)
8. Atkins T, Prior RG, Mack K, Russell P, Nelson M, Oyston PCF, Dougan G, Titball RW. 2002. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect. Immun. 70:5290-5294.
9. Norris MH, Propst KL, Kang Y, Dow SW, Schweizer HP, Hoang TT. 2011. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Infect. Immun. 79:4010-4018.
10. Dannenberg AM, Scott EM. 1960. Melioidosis: pathogenesis and immunity in mice and hamsters. III. Effect of vaccination with avirulent strains of Pseudomonas pseudomallei on the resistance to the establishment and the resistance to the progress of respiratory melioidosis caused by virulent strains; all-or-none aspects of this disease. J. Immunol. 84:233-246.
11. Levine HB, Maurer RL. 1958. Immunization with an induced avirulent auxotrophic mutant of Pseudomonas pseudomallei. J. Immunol. 81:433-438.
12. Srilunchang T, Proungvitaya T, Wongratanacheewin S, Strugnell R, Homchampa P. 2009. Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2. Southeast Asian J. Trop. Med. Public Health 40:123-130.
13. Breitbach K, Kohler J, Steinmetz I. 2008. Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle. Trans. R. Soc. Trop. Med. Hyg. 102:S89-S94.
14. DeShazer D. 2007. Virulence of clinical and environmental isolates of Burkholderia oklahomensis and Burkholderia thailandensis in hamsters and mice. FEMS Microbiol. Lett. 277:64-69. (Pubitemid 350045662)
15. Glass MB, Gee JE, Steigerwalt AG, Cavuoti D, Barton T, Hardy RD, Godoy D, Spratt BG, Clark TA, Wilkins PP. 2006. Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J. Clin. Microbiol. 44:4601-4604. (Pubitemid 44937108)
16. Lertpatanasuwan N, Sermsri K, Petkaseam A, Trakulsomboon S, Thamlikitkul V, Suputtamongkol Y. 1999. Arabinose-positive Burkholderia pseudomallei infection in humans: case report. Clin. Infect. Dis. 28:927-928. (Pubitemid 29169452)
17. Iliukhin VI, Senina TV, Plekhanova NG, Antonov VA, Merinova LK, Seimova IK. 2002. Burkholderia thailandensis: biological properties, identification and taxonomy. Mol. G. Mikrobiol. Virusol. 1:7-11. (In Russian.)
18. Reckseidler SL, DeShazer D, Sokol PA, Woods DE. 2001. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect. Immun. 69:34-44. (Pubitemid 32038296)
19. Brett PJ, DeShazer D, Woods DE. 1998. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int. J. Syst. Bacteriol. 48(Pt 1):317-320. (Pubitemid 28144666)
20. Arnon R. 2011. Overview of vaccine strategies, p 1-20. In Rappuoli R, Bagnoli F (ed), Vaccine design: innovative approaches and novel strategies, 1st ed. Caister Academic Press, Norfolk, United Kingdom.
21. Sim BMQ, Chantratita N, Ooi WF, Nandi T, Tewhey R, Wuthiekanun V, Thaipadungpanit J, Tumapa S, Ariyaratne P, Sung WK, Sem XH, Chua HH, Ramnarayanan K, Lin CH, Liu YC, Feil EJ, Glass MB, Tan G, Peacock SJ, Tan P. 2010. Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol. 11:R89.
22. Scott AE, Twine SM, Fulton KM, Titball RW, Essex-Lopresti AE, Atkins TP, Prior JL. 2011. Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis. J. Bacteriol. 193:3577-3587.
23. Goke J, Schulz MH, Lasserre J, Vingron M. 2012. Estimation of pairwise sequence similarity of mammalian enhancers with word neighbourhood counts. Bioinformatics 28:656-663.
24. Sarkar-Tyson M, Smither SJ, Harding SV, Atkins TP, Titball RW. 2009. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Vaccine 27:4447-4451.
25. Nelson M, Prior JL, Lever MS, Jones HE, Atkins TP, Titball RW. 2004. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J. Med. Microbiol. 53:1177-1182. (Pubitemid 40052471)
26. Ngugi SA, Ventura VV, Qazi O, Harding SV, Kitto G, Estes D, Dell A, Titball RW, Atkins TP, Brown KA, Hitchen PG, Prior JL. 2010. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Vaccine 28:7551-7555.
27. Atkins T, Prior R, Mack K, Russell P, Nelson M, Prior J, Ellis J, Oyston PCF, Dougan G, Titball RW. 2002. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J. Med. Microbiol. 51:539-547. (Pubitemid 34747982)
28. Ellis J. 2000. Antibody detection of Burkholderia pseudomallei and Burkholderia mallei. Ph.D. thesis. Aston University Birmingham, United Kingdom.
29. Anuntagool N, Wuthiekanun V, White NJ, Currie BJ, Sermswan RW, Wongratanacheewin S, Taweechaisupapong S, Chaiyaroj SC, Strisinha S. 2006. Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am. J. Trop. Med. Hyg. 74:348-352. (Pubitemid 46774353)
30. Burtnick MN, Brett PJ, Woods DE. 2002. Molecular and physical characterization of Burkholderia mallei O antigens. J. Bacteriol. 184:849-852. (Pubitemid 34150234)
31. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. 1999. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:2291-2298. (Pubitemid 29288853)
32. Klinman DM, Conover J, Coban C. 1999. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect. Immun. 67:5658-5663. (Pubitemid 29508083)
33. Haraga A, West TE, Brittnacher MJ, Skerrett SJ, Miller SI. 2008. Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. Infect. Immun. 76:5402-5411.
34. Smith MD, Angus BJ, Wuthiekanun V, White NJ. 1997. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect. Immun. 65:4319-4321. (Pubitemid 27422093)
35. Brett PJ, DeShazer D, Woods DE. 1997. Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol. Infect. 118:137-148. (Pubitemid 27170805)
36. Iliukhin VI, Kislichkin NN, Merinova LK, Riapis LA, Denisov II, Farber SM, Kislichkina OI. 1999. The efficacy and outlook for the study of live vaccines for the prevention of melioidosis. Zh. Mikrobiol. Epidemiol. Immunobiol. 49-51. (In Russian.)
37. Zhang S, Feng SH, Li B, Kim HY, Rodriguez J, Tsai S, Lo SC. 2011. In vitro and in vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei. Clin. Vaccine Immunol. 18:825-834.
38. Jones SM, Ellis JF, Russell P, Griffin KF, Oyston PCF. 2002. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J. Med. Microbiol. 51:1055-1062. (Pubitemid 36020726)
39. Brett PJ, Woods DE. 1996. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect. Immun. 64:2824-2828. (Pubitemid 26226855)
40. Ho M, Schollaardt T, Smith MD, Perry MB, Brett PJ, Chaowagul W, Bryan LE. 1997. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. 65:3648-3653. (Pubitemid 27398120)
41. AuCoin DP, Reed DE, Marlenee NL, Bowen RA, Thorkildson P, Judy BM, Torres AG, Kozel TR. 2012. Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei. PLoS One 7:e35386. doi:10.1371/journal.pone.0035386.
42. Charuchaimontri C, Suputtamongkol Y, Nilakul C, Chaowagul V, Chetchotisakd P, Lertpatanasuwun N, Intaranongpai S, Brett PJ, Woods DE. 1999. Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin. Infect. Dis. 29:813-818. (Pubitemid 30256374)
43. Hoppe I, Brenneke B, Rohde M, Kreft A, Haussler S, Reganzerowski A, Steinmetz I. 1999. Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect. Immun. 67:2891-2900. (Pubitemid 29244705)
44. Tan GYG, Liu Y, Sivalingam SP, Sim SH, Wang D, Paucod JC, Gauthier Y, Ooi EE. 2008. Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57BI/6 mice. J. Med. Microbiol. 57:508-515. (Pubitemid 351537028)